RxDoctor Payments Data

Jennifer Avis, APRN

Family · Louisville, KYNPI 1467179721

Payments from drug & device makers

$631in general payments, 2019–2025

Across 33 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shield Therapeutics Inc$161
  • Bayer$54
  • Pfizer$50
  • Gilead$46
  • Astellas Pharma US Inc$42
  • Novo Nordisk$36
  • plus $243 from 10 others

What the payments were for

  • Food & beverage$631100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$631 in reported general payments places this provider in the 55th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$536
Medicare patients
35
Services billed
77

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide90$123,731
JardianceEmpagliflozin38$33,777
JanuviaSitagliptin Phosphate37$30,275
EliquisApixaban24$23,851
FarxigaDapagliflozin Propanediol12$18,232
Breo ElliptaFluticasone/Vilanterol12$6,367
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$5,986
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$5,976
Advair HfaFluticasone Propion/Salmeterol12$5,959
SymbicortBudesonide/Formoterol Fumarate11$4,267
Albuterol Sulfate HfaAlbuterol Sulfate83$3,409
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$3,290
Ventolin HfaAlbuterol Sulfate25$1,887
Hydroxyzine Hcl58$1,146
Atorvastatin Calcium164$979

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$36$123,73190 claims
MerckJanuvia$35$30,27537 claims
PfizerEliquis$50$23,85124 claims
GSKBreo Ellipta, Anoro Ellipta$29$12,34327 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,374 family providers in Kentucky.

Other family in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →